Snowball logo
logo
HBC_logo

Hofseth Biocare ASA

NOK 1.315-NOK 0.02  (1.5%)
Estimate
EPS
-0.34
Beta
0.248
Growth
Revenue, YoY
-4.02%
Net income, YoY
7.09%
FCF, YoY
84.62%
About the company
Ticker
HBC
ISIN
NO0010598683
Country
Norway
Sector (GICS)
Healthcare
Hofseth BioCare ASA produces and sells health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, Turkey, rest of Europe, Japan, Asia, and the United States. The company offers ProGo, a bioactive peptide for weight management and metabolic health; OmeGo, a fish oil that provides a full spectrum of fatty acids and omegas; CalGo and NT-II, which are calcium collagen complexes that support joint and bone health; CollaGo; and PetGo, a non-soluble protein. Hofseth BioCare ASA was founded in 2000 and is headquartered in Ålesund, Norway.

Frequently asked questions

What sector does Hofseth Biocare ASA (HBC) operate in?

Hofseth Biocare ASA belongs to the Healthcare sector and operates in the Packaged Foods industry.

What is Hofseth Biocare ASA (HBC) current stock price?

As of the latest data, Hofseth Biocare ASA stock price is NOK 1.32, with a previous close of NOK 1.34. Hofseth Biocare ASA lost -NOK 0.02 in the last trading session, representing a -1.5% loss.

What is Hofseth Biocare ASA (HBC) current market capitalization?

Hofseth Biocare ASA market cap is approximately 665.69 million.

What is Hofseth Biocare ASA (HBC) Earnings Per Share (EPS)?

The trailing EPS is -NOK 0.34.

What is Hofseth Biocare ASA (HBC) EBITDA?

Hofseth Biocare ASA EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -5.33 million.

Does Hofseth Biocare ASA (HBC) pay dividends?

No. Hofseth Biocare ASA does not pay a dividend.

What is Hofseth Biocare ASA (HBC) beta (volatility) score?

Hofseth Biocare ASA has a beta of 0.248, indicating lower volatility than the overall market.